Please find attached the BRSR Report for FY 2025-26.

Date: 04-09-2026 To To The General Manager The Manager Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Mumbai - 400 051 Scrip Code at BSE: 533259 Symbol at NSE: HEALTHX Subject: Business Responsibility and Sustainability Report of the Company for the FY 2025-26 Dear Sir/ Madam, Pursuant to the Regulation 34 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the Business Responsibility and Sustainability Report ('BRSR') of the Company for the Financial Year 2025-26. The Business Responsibility and Sustainability Report is also available on the Company’s website at www.healthxplatform.com. Kindly take the aforesaid information on record. Thanking you, Yours faithfully, For Health X Platform Limited (formerly known as Sastasundar Ventures Limited) Pratap Singh Company Secretary & Compliance Officer M. No.: A24081 Encl: As above Statutory Reports Standalone Financials Consolidated Financials 25 BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT Annexure V BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT For the financial year 2025-26 SECTION A: GENERAL DISCLOSURES I Details of the listed entity 1. Corporate Identity Number (CIN) of the Listed Entity L65993WB1989PLC047002 2. Name of the Listed Entity HEALTH X PLATFORM LIMITED (Formerly Sastasundar Ventures Limited) 3. Year of incorporation 06/06/1989 4. Registered office address Azimganj House, 2nd Floor, 7 Abanindra Nath Thakur Sarani (Formerly Camac Street), Kolkata - 700017 5. Corporate address Azimganj House, 2nd Floor, 7 Abanindra Nath Thakur Sarani (Formerly Camac Street), Kolkata - 700017 6. E-mail investors@sastasundar.com 7. Telephone +91 33 2282 9330 8. Website www.healthxplatform.com 9. Financial year for which reporting is being done 2025-2026 10. Name of the Stock Exchange(s) where shares are listed BSE & NSE 11. Paid-up Capital Rs 3181.05 Lakhs 12. Name and contact details (telephone, email address) of the Mr. Banwari Lal Mittal (DIN 00365809) person who may be contacted in case of any queries on the BRSR Chairman & Managing Director report Tel: 033 22829330 Email: investors@sastasundar.com 13. Reporting boundary - Are the disclosures under this report made Consolidated Basis on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together) 14. Name of Assurance Provider Not Applicable 15. Type of Assurance Obtained Not Applicable II Products/services 16. Details of business activities (accounting for 90% of the turnover) S. No. Description of Main Activity Description of Business Activity % of Turnover of the entity 1 Sale of traded goods (medicines Wholesale trading of 98.80% and OTC products) pharmaceutical and OTC products 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover) S. No. Product/Service NIC Code % of total Turnover contributed 1 Wholesale of pharmaceutical 46497 98.80% and medical goods 46901 Wholesale trade of other OTC products 2 Other Financial Service 64990 0.002% activities 26 HEALTH X PLATFORM LIMITED BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT III Operations 18. Number of locations where plants and/or operations/offices of the entity are situated Location Number of plants Number of offices Total National - 3 (Note) 3 International - - - Note: All three office are located at Kolkata. Apart from this, there are 3 fulfilment centres including 1 represented above. 19. Markets served by the entity a. Number of locations Locations Number National (No. of States) PAN India International (No. of Countries) 0 b. What is the contribution of exports as a percentage of Nil the total turnover of the entity? c. A brief on types of customers Health X Platform Limited (formerly Sastasundar Ventures Limited) is a Core Investment Company exempted from registration with the Reserve Bank of India. 90% of the funds are invested in the subsidiaries of the Company. Sastasundar Healthbuddy Limited is a subsidiary engaged in wholesale business to support the seller pharmacy network of Sastasundar App. Sastasundar Healthbuddy Limited is managing the supply chain of medicine and wellness products. On the other hand, Retailer Shakti supplies medicine, wellness products and FMCG products to retail pharmacies and serves B2B customers. IV. Employees 20. Details as at the end of Financial Year 2025-26 a. Employees and workers (including differently abled) S. Particulars Total (A) Male Female No. No. (B) % (B / A) No. (C) % (C / A) EMPLOYEES 1. Permanent (D) 2760 2577 93.37% 183 6.63% 2. Other than Permanent (E) - - - - - 3. Total employees (D + E)* 2760 2577 93.37% 183 6.63% * Includes employees of subsidiaries. WORKERS 4. Permanent (F) - - - - - 5. Other than Permanent (G) - - - - - 6. Total workers (F + G) - - - - - b. Differently abled Employees and workers: Statutory Reports Standalone Financials Consolidated Financials 27 BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT S. Particulars Total Male Female No (A) No. (B) % (B / A) No. (C) % (C / A) DIFFERENTLY ABLED EMPLOYEES 1. Permanent (D) 1 1 100% - - 2. Other than Permanent (E) - - - - - 3. Total differently abled employees (D + E) 1 1 100% - - DIFFERENTLY ABLED WORKERS 4. Permanent (F) - - - - - 5. Other than permanent (G) - - - - - 6. Total differently abled workers (F + G) - - - - - 21 Participation/Inclusion/Representation of women – No. and percentage of Females Total (A) No. (B) % (B / A) Board of Directors 6 3 50.00% Key Management Personnel 3 0 0.00% Note: The figures provided pertains to listed entity. 22 Turnover rate for permanent employees and workers FY 2025-26 FY 2024-25 FY 2023-24 (Turnover rate in current FY) (Turnover rate in previous FY) (Turnover rate in the year prior to the previous FY) Male Female Total Male Female Total Male Female Total Permanent Employees 44% 42% 43% 33% 59% 35% 56% 63% 57% Permanent Workers - - - - - - - - - V Holding, Subsidiary and Associate Companies (including joint ventures) 23(a) Names of holding / subsidiary / associate companies / joint ventures S. Name of the holding /subsidiary/ Indicate whether % of shares Does the entity indicated No. associate companies / joint ventures holding/ Subsidiary/ held by at column A, participate in (A) Associate/ Joint listed the Business Responsibility Venture entity initiatives of the listed entity? (Yes/ No) 1 Sastasundar Healthbuddy Limited Subsidiary 78.89% 2 Genu Path Labs Limited Subsidiary 78.89% 3 Sastasundar Healthtech Private Limited Subsidiary 78.89% 4 Innogrow Technologies Limited Subsidiary 100% 5 Myjoy Technologies Private Limited Subsidiary 100% 6 Microsec Resources Private Limited Subsidiary 100% 7 Bharatiya Sanskriti Village Private Limited Subsidiary 100% 8 Microsec Wealth Management Limited Subsidiary 100% 28 HEALTH X PLATFORM LIMITED BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT VI CSR Details 24 (i) Whether CSR is applicable as per section 135 of Companies Act, 2013: (Yes/No) No Turnover (in Rs.) 75,98,073 Net worth (in Rs.) 2,70,85,56,875 VII Transparency and Disclosures Compliances 25. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible Business Conduct Stakeholder Grievance Redressal FY 2025-26 FY 2024-25 group from whom Mechanism in Place (Yes/ Current Financial Year Previous Financial Year complaint is No) Number of Number of Number of Number of received (If Yes, then provide web- complaints complaints complaints complaints link for grievance redress filed during pending Remarks filed pending Remarks policy) the year resolution at during the resolution at close of the year year close of the year Communities Nil Nil Nil Nil Nil Nil Investors (other than Nil Nil Nil Nil Nil Nil [Showing first 8,000 characters — download PDF for full document]